scholarly article | Q13442814 |
P2093 | author name string | Sharlene M Day | |
Timir S Baman | |||
Sanjaya Gupta | |||
P2860 | cites work | Prevalence and clinical significance of left atrial remodeling in competitive athletes | Q81055890 |
Brugada syndrome | Q81657704 | ||
Marfan's syndrome | Q24553344 | ||
Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
Common issues in sports cardiology | Q30437321 | ||
Task Force 7: arrhythmias | Q33152547 | ||
Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond | Q33156900 | ||
Bradycardia, ventricular pauses, syncope, and sports | Q33172111 | ||
Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy | Q33287095 | ||
Sudden death in young athletes | Q34229613 | ||
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. | Q34325441 | ||
Medical management of Marfan syndrome | Q34782039 | ||
Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations | Q36101154 | ||
Task Force 2: congenital heart disease | Q36101162 | ||
Task Force 3: valvular heart disease | Q36101167 | ||
Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome | Q36101172 | ||
Task Force 5: systemic hypertension | Q36101177 | ||
Task Force 6: coronary artery disease | Q36101182 | ||
Task Force 8: classification of sports | Q36101187 | ||
Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group | Q36143592 | ||
The congenital long QT syndrome and implications for young athletes | Q36467804 | ||
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutation | Q36999467 | ||
Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision | Q37183616 | ||
Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. | Q37341067 | ||
Prevalence of the congenital long-QT syndrome. | Q37442080 | ||
Athletes and arrhythmias: clinical considerations and perspectives | Q41057202 | ||
The 1998 NASPE prospective catheter ablation registry | Q41744925 | ||
Intrinsic sinus and atrioventricular node electrophysiologic adaptations in endurance athletes | Q43919820 | ||
Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. | Q44079560 | ||
It is not prudent to allow all athletes with implantable-cardioverter defibrillators to participate in all sports | Q47723497 | ||
Right bundle branch block, right precordial st-segment elevation, and sudden death in young people | Q48705967 | ||
Task Force 10: automated external defibrillators. | Q51498881 | ||
Long QT syndrome. | Q53213950 | ||
Sport practice and the risk of lone atrial fibrillation: A case–control study | Q57235832 | ||
High Efficacy of β-Blockers in Long-QT Syndrome Type 1 | Q58010685 | ||
Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis | Q58910617 | ||
Ventricular ectopy in athletes: don't worry...more good news! | Q74523239 | ||
Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition | Q80677881 | ||
Atrial fibrillation in athletes: toward more effective therapy and better understanding | Q80947072 | ||
P433 | issue | 1 | |
P304 | page(s) | 19-28 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Sports Health: A Multidisciplinary Approach | Q7579733 |
P1476 | title | Cardiovascular health, part 2: sports participation in athletes with cardiovascular conditions | |
P478 | volume | 2 |
Q35096624 | Athletic differences in the characteristics of the photoplethysmographic pulse shape: effect of maximal oxygen uptake and maximal muscular voluntary contraction. |
Q36242081 | Cardiac risks associated with marathon running |
Q36841370 | Radial pulse waveform and parameters in different types of athletes |
Q38642966 | Top 10 Research Questions Related to Preventing Sudden Death in Sport and Physical Activity. |
Search more.